Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe
 

TON - March 2017, Vol 10, No 2

The endocrine therapy landscape has evolved from tamoxifen and aromatase inhibitors to CDK4/6 inhibitors and mTOR inhibitors.
Occupational factors such as shift work disrupt circadian rhythm and can increase breast cancer risk, and the International Agency for Research on Cancer has classified shift work as a possible carcinogen.
Breast density, which can affect the visualization of mammography, is one of the strongest and most consistent risk factors for breast cancer.
Breast cancer rates are increasing worldwide, paralleling increases in type 2 diabetes, obesity, and metabolic syndrome (MetS).
Daily moderate physical activity can improve outcomes in patients with metastatic colorectal cancer (CRC).
Toxicities related to immunotherapies approved for the treatment of patients with non–small-cell lung cancer (NSCLC) are uncommon but can be life-threatening.
With an estimated 15.5 million cancer survivors living in the United States, there is an increased recognition of the need for continuing education of healthcare providers focused on this growing population.
As a result of differences in biology, access to care, and psychosocial and socioeconomic circumstances, adolescent and young adult (AYA) patients with cancer face distinct challenges compared with their adult counterparts.
Survivors of lower gastrointestinal cancers can successfully use Internet-based patient-reported outcomes tools to report late- and long-term effects of their cancer.
  • Venetoclax plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
  • Adding Antiandrogen to Radiation Therapy Extends Survival in Relapsed Prostate Cancer
Page 2 of 3
Results 11 - 20 of 22